论文部分内容阅读
目的探讨舒血宁注射液治疗急性脑梗死的临床效果。方法选取我院收治的120例急性脑梗死患者为研究对象,随机分为对照组和观察组,两组均给予常规对症治疗,对照组在常规治疗的基础上加用复方丹参注射液治疗,观察组在常规治疗的基础上加用舒血宁注射液治疗,比较两组治疗效果及神经功能改善情况。结果观察组总有效率显著高于对照组,差异有统计学意义(P<0.05)。两组治疗前脑梗死体积、神经功能缺损程度评分经统计学分析,差异无统计学意义(P>0.05)。观察组治疗后脑梗死体积、神经功能缺损程度评分显著优于对照组,差异有统计学意义(P<0.05)。结论采用舒血宁注射液治疗急性脑梗死疗效优于复方丹参注射液治疗,治疗后梗死体积减少显著,神经功能损伤恢复良好,值得临床推广应用。
Objective To investigate the clinical effect of Shuxuening injection in the treatment of acute cerebral infarction. Methods A total of 120 acute cerebral infarction patients admitted to our hospital were selected as control subjects and observation group. Both groups were given conventional symptomatic treatment. The control group was treated with compound Danshen injection on the basis of conventional treatment. On the basis of conventional treatment, Shuxuening injection was used to treat the patients. The therapeutic effects and the improvement of nerve function were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). The two groups before treatment of cerebral infarction volume, neurological deficit score by statistical analysis, the difference was not statistically significant (P> 0.05). The volume of cerebral infarction and the degree of neurological deficit in the observation group were significantly better than those in the control group, the difference was statistically significant (P <0.05). Conclusion Shuxuening injection is superior to Fufang Danshen injection in the treatment of acute cerebral infarction. After treatment, the volume of infarction is significantly reduced and the neurological function is recovered well. It is worthy of clinical application.